Concepedia

Martin Steegmaier

MS

22

Publications

4.3K

Citations

20

H-Index

1997

Active since

Affiliations

Stanford University(Current)

Howard Hughes Medical Institute

Boehringer Ingelheim (Austria)

Boehringer Ingelheim (Germany)

University of Münster

Martin Steegmaier is an author at Stanford University specializing in medicine, cell biology, and signal transduction.

Top concepts

Publications per year

1997–2021

22

Publications

22

BI 2536, a Potent and Selective Inhibitor of Polo-like Kinase 1, Inhibits Tumor Growth In Vivo

Martin Steegmaier, Matthias Hoffmann, Anke Baum et al. · Current Biology · 2007 · 839 citations · Full text

, , +9

The Small-Molecule Inhibitor BI 2536 Reveals Novel Insights into Mitotic Roles of Polo-like Kinase 1

Péter Lénárt, Mark Petronczki, Martin Steegmaier et al. · Current Biology · 2007 · 675 citations · Full text

, , +12

BI 6727, A Polo-like Kinase Inhibitor with Improved Pharmacokinetic Profile and Broad Antitumor Activity

Dorothea Rudolph, Martin Steegmaier, Matthias Hoffmann et al. · Clinical Cancer Research · 2009 · 388 citations · Full text

SNARE Interactions Are Not Selective

Bin Yang, Lino C. Gonzalez, Rytis Prekeris et al. · Journal of Biological Chemistry · 1999 · 315 citations · Full text

, , +14

BI-D1870 is a specific inhibitor of the p90 RSK (ribosomal S6 kinase) isoforms<i>in vitro</i>and<i>in vivo</i>

Gopal P. Sapkota, Lorna Cummings, Felicity Newell et al. · Biochemical Journal · 2006 · 301 citations · Full text

, , +21

Rows per page

1–5 of 22